Pcn20 the Budgetary Impact of Pemetrexed Plus Cisplatin as First-line Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer (nsclc)
Year: 2009
Type: conference-abstract
Source: Value in Health
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W1968436715
